Document:

Exhibit 10.5

 

MEMBER
SUPPORT AGREEMENT

 

This MEMBER SUPPORT AGREEMENT
(this “Agreement”), dated as of August 9, 2021, is made by and among Astrea Acquisition Corp., a Delaware corporation
(“Acquiror”), the Persons set forth on Schedule I hereto (the “Required Members”), and Benjamin
& Brothers, LLC, a Florida limited liability company (the “Company”). The Required Members, Acquiror and the Company
shall be referred to herein from time to time collectively as the “Parties.”

 

WHEREAS,
as of the date hereof, the Required Members are the holders of such class and number of units of the Company as are indicated opposite
their respective names on Schedule I attached hereto (together with any other Equity Securities of the Company that any Required
Member acquires record or beneficial ownership of after the date hereof until the Termination Date (as defined below), collectively,
the “Subject Company Equity Securities”);

 

WHEREAS,
Acquiror, the Company and certain other Persons party thereto entered into the Agreement and Plan of Merger, dated as of the date hereof
(as it may be amended, restated or otherwise modified from time to time in accordance with its terms, the “Merger Agreement”).
Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement;
and

 

WHEREAS,
the Merger Agreement contemplates that the Parties will enter into this Agreement concurrently therewith, pursuant to which, among other
things, the Required Members will not transfer the Subject Company Equity Securities until the Termination Date.

 

NOW,
THEREFORE, the Parties hereby agree as follows:

 

1. Binding
Effect of Merger Agreement. Each Required Member hereby acknowledges that such Required Member has read the Merger Agreement and
this Agreement and has had the opportunity to consult with such Required Member's tax and legal advisors. Each Required Member shall
be bound by and comply with Sections 8.03(a) (Exclusivity) and 8.05 (Confidentiality; Publicity) of the Merger Agreement
(and any relevant definitions contained in any such Sections) as if such Required Member was an original signatory to the Merger Agreement
with respect to such provisions.

 

2. No
Transfer.

 

(a) During
the period commencing on the date hereof and ending on the earlier to occur of (i) the HotelPlanner.com Effective Time and (ii) the valid
termination of the Merger Agreement in accordance with its terms (the earlier of such dates, the “Termination Date”),
no Required Member shall (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise
dispose of or agree to dispose of, directly or indirectly, file (or participate in the filing of) a registration statement with the SEC
(other than the Proxy Statement) or establish or increase a put equivalent position or liquidate or decrease a call equivalent position
within the meaning of Section 16 of the Exchange Act (collectively “Transfer”), with respect to any shares of Acquiror
Common Stock, any units of Acquiror (“Acquiror Units”), Acquiror Warrants, or any other Equity Securities of Acquiror
that such Required Member owns or acquires record or beneficial ownership of after the date hereof until the Termination Date, (collectively,
the “Subject Acquiror Equity Securities”), (ii) enter into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of any Subject Acquiror Equity Securities or (iii) publicly announce
any intention to effect any transaction specified in clause (i) or (ii); provided, however, that nothing herein shall prohibit a Transfer
of any Subject Acquiror Equity Securities with the prior written consent of Acquiror and the Company (which consent shall not be unreasonably
withheld, conditioned, or delayed) by private sales made at or prior to the consummation of the Merger if, as a precondition to such
Transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to the Company and Acquiror, to assume all
of the obligations of the transferring Required Member under, and be bound by all of the terms of, this Agreement; provided, further,
that any Transfer permitted under this Section 2(a) shall not relieve the transferring Shareholder of its obligations under this
Agreement. Any Transfer in violation of this Section 2(a) with respect to the Subject Acquiror Equity Securities shall be null
and void.

 

    

    

    

 

(b) During
the period commencing on the date hereof and ending on the Termination Date, except in connection with the consummation of the Transactions,
or with the prior written consent of Acquiror, no Required Member shall, directly or indirectly, (i) Transfer or enter into any Contract
or option with respect to the Transfer of any of the Subject Company Equity Securities; (ii) enter into any swap or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Company Equity Securities,
(iii) publicly announce any intention to effect any transaction specified in clauses (i) or (ii), or (iv) take any action that would
make any representation or warranty of any such Required Member contained herein untrue or incorrect or have the effect of preventing
or disabling such Required Member from performing its obligations under this Agreement; provided, however, that nothing herein shall
prohibit a Transfer to an Affiliate of any such Required Member (a “Permitted Transfer”); provided, further, that
any Permitted Transfer shall be permitted only if, as a precondition to such Transfer, the transferee agrees in a writing, reasonably
satisfactory in form and substance to the Company and Acquiror, to assume all of the obligations of such transferring Required Member
under, and be bound by all of the terms of, this Agreement with respect to such transferred Subject Company Equity Securities; provided,
further, that any Transfer permitted under this Section 2(b) shall not relieve such transferring Required Member of its obligations
under this Agreement. Any Transfer in violation of this Section 2(b) with respect to the Subject Company Equity Securities shall
be null and void. Nothing in this Agreement shall prohibit direct or indirect transfers of equity or other interests in a Required Member.

 

3. Registration
Rights Agreement. On the Closing Date, the Required Members shall deliver to the Company a duly executed copy of that certain Amended
and Restated Registration Rights Agreement, by and among the Company, the Sponsor, and certain of the Company’s equityholders or
their respective affiliates, including the Required Members, in substantially the form attached as Exhibit D to the Merger Agreement.

 

4. Agreement
to Vote. From the date hereof until the Expiration Time, each Required Member hereby agrees:

 

(i)
to vote (or cause to be voted) or execute and deliver a written consent (or cause a written consent to be executed and delivered) at
any meeting of the members of the Company, however called, or at any adjournment thereof, or in any other circumstance in which the vote,
consent or other approval of the members of the Company is sought (and, in the case of a meeting of the members, appear at any such meeting,
in person or by proxy, or otherwise cause all of such holder’s Subject Company Equity Securities to be counted as present thereat
for purposes of establishing a quorum), all of such Required Member’s Subject Company Equity Securities:

 

(A)
in favor of the Merger Agreement and the Transactions;

 

    2

    

    

 

(B)
against any merger agreement or merger, consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution,
liquidation or winding up of or by the Company (other than the Merger Agreement and the Transactions);

 

(C)
against any proposal in opposition to approval of the Merger Agreement or in competition with or inconsistent with the Merger Agreement
or the Transactions; and

 

(D)
against any proposal, action or agreement that would (1) impede, frustrate, prevent or nullify any provision of this Agreement, the Merger
Agreement or the Transactions, (2) result in a breach in any respect of any covenant, representation, warranty or any other obligation
or agreement of the Company under the Merger Agreement, (3) result in any of the conditions set forth in Article 9 of the Merger Agreement
not being fulfilled or (4) change in any manner the distribution policy or capitalization of, including the voting rights of any class
of equity securities of, the Company.

 

(ii)
not to commit or agree to take any action inconsistent with the foregoing.

 

5. Proxy.

 

(a) The obligations of each Required Member specified in Section 4 shall apply whether or not the Transactions or any action
described above is recommended by the co-managers of the Company or the co-managers of the Company have previously recommended the Transactions
or such action but changed such recommendation.

 

(b) Each
Required Member hereby irrevocably and unconditionally, to the fullest extent permitted by applicable Law, appoints the Company, or any
designee of the Company, for so long as the provisions of Section 4 remain in effect, as such Required Member’s attorney-in-
fact and proxy with full power of substitution, to vote, express consent or dissent and otherwise act (by written consent or otherwise)
with respect to the Subject Company Equity Securities, solely on the matters and in the manner specified in Section 4 and solely
in the event that such Required Member fails to perform or otherwise comply with the covenants, agreements or obligations set forth in
Section 4. This proxy (including, for the avoidance of doubt, any voting proxy delivered pursuant to Section 4) shall be
valid for the duration of this Agreement.

 

    3

    

    

 

(c) THE
PROXIES AND POWERS OF ATTORNEY GRANTED PURSUANT TO THIS SECTION 5 ARE IRREVOCABLE AND COUPLED WITH AN INTEREST. Each Required
Member hereby affirms that the irrevocable proxy granted by each such Required Member pursuant to this Section 5 (including, for
the avoidance of doubt, any voting proxy delivered pursuant to Section 4) is granted in consideration of the Company entering
into this Agreement and the Merger Agreement and that such irrevocable proxy is given to secure the performance of the duties of any
such Required Member under this Agreement. The proxies and powers of attorney shall not be terminated by any act of any such Required
Member or by operation of law, by lack of appropriate power or authority, or by the occurrence of any other event or events and shall
be binding upon all successors, assigns, heirs, beneficiaries and legal representatives of each such Required Member. Each Required Member
hereby revokes all other proxies and powers of attorney on the matters specified in this Section 5 with respect to the Subject
Company Equity Securities that each such Required Member may have previously appointed or granted, and no subsequent proxy or power of
attorney shall be given or written consent executed (and if given or executed, shall not be effective) by any such Required Member with
respect to any Subject Company Equity Securities. All authority herein conferred or agreed to be conferred shall survive the death, bankruptcy
or incapacity of each such Required Member and any obligation of each such Required Member under this Agreement shall be binding upon
the heirs, personal representatives, and successors of each such Required Member. The proxyholder may not exercise the proxy granted
pursuant to this Section 5 on any matter except those provided in Section 4. For the avoidance of doubt, the Required Member
may vote the Subject Company Equity Securities on all other matters, subject, in all cases, to the other applicable covenants, agreements
and obligations set forth in this Agreement.

 

6. Representations
and Warranties. Each Required Member, severally and not jointly, represents and warrants to Acquiror and the Company, only with respect
to itself, as follows:

 

(a) (i)
If the Required Member is a natural person, he or she has all the requisite power and authority and has taken all action necessary in
order to execute and deliver this Agreement, to perform his or her obligations hereunder and to consummate the transactions contemplated
hereby, and (ii) if the Required Member is not a natural person, it is duly organized, validly existing and in good standing under the
laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance of
this Agreement and the consummation of the transactions contemplated hereby are within such Required Member’s corporate, limited
liability company or organizational powers and have been duly authorized by all necessary corporate, limited liability company, or organizational
actions on the part of such Required Member. This Agreement has been duly executed and delivered by such Required Member and, assuming
due authorization, execution and delivery by the other Parties hereto, this Agreement constitutes a legally valid and binding obligation
of such Required Member, enforceable against such Required Member in accordance with the terms hereof (except as enforceability may be
limited by bankruptcy Laws, other similar Laws affecting creditors’ rights and general principles of equity affecting the availability
of specific performance and other equitable remedies).

 

    4

    

    

 

(b) Such
Required Member is the record and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good title to,
all of its Subject Company Equity Securities, and there exist no Liens or any other limitation or restriction (including any restriction
on the right to vote, sell or otherwise dispose of such Subject Company Equity Securities (other than transfer restrictions under the
Securities Act)) affecting any such Subject Company Equity Securities, other than Liens pursuant to (i) this Agreement, (ii) the Company’s
organizational documents, (iii) the Merger Agreement, or (iv) any applicable securities Laws. Such Required Member’s Subject Company
Equity Securities are the only equity securities of the Company owned of record or beneficially by such Required Member on the date of
this Agreement, and none of such Required Member’s Subject Company Equity Securities are subject to any proxy, voting trust or
other agreement or arrangement with respect to the voting of such Subject Company Equity Securities, except as provided hereunder. Such
Required Member does not hold or own any Subject Acquiror Equity Securities and does not hold or own any rights to acquire (directly
or indirectly) any equity securities of the Acquiror or any equity securities convertible into, or which can be exchanged for, equity
securities of the Acquiror.

 

(c) The
execution and delivery of this Agreement by such Required Member does not, and the performance by such Required Member of its obligations
hereunder will not, (i) if the Required Member is not a natural person, conflict with or result in a violation of the organizational
documents of such Required Member, or (ii) require any consent or approval that has not been given or other action that has not been
taken by any third party (including under any Contract binding upon such Required Member or such Required Member’s Subject Company
Equity Securities), in each case, to the extent such consent, approval or other action would prevent, enjoin or materially delay the
performance by such Required Member of its obligations under this Agreement.

 

(d) There
are no Actions pending against such Required Member or, to the knowledge of such Required Members, threatened against such Required Member,
before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, which in any manner
challenges or seeks to prevent, enjoin or materially delay the performance by such Required Member of his, her or its obligations under
this Agreement.

 

(e) Except
as described on Schedule 4.24 to the Merger Agreement, no broker, finder, investment banker or other Person is entitled to any brokerage
fee, finders’ fee, underwriting fee, deferred underwriting fee, commission or other similar payment in connection with the Transactions
based upon arrangements made by such Required Member, for which the Company or any of its Affiliates may become liable.

 

(f) Such
Required Member understands and acknowledges that each of Acquiror and each Company Party is entering into the Merger Agreement in reliance
upon the Required Members’ execution and delivery of this Agreement.

 

    5

    

    

 

7. Termination. This Agreement shall automatically terminate, without any notice or other action by any Party, and be void
ab initio on the Termination Date. Upon termination of this Agreement as provided in the immediately preceding sentence, none of the Parties
shall have any further obligations or liabilities under, or with respect to, this Agreement. Notwithstanding the foregoing or anything
to the contrary in this Agreement, (i) the termination of this Agreement shall not affect any liability on the part of any Party for a
Willful Breach of any covenant or agreement set forth in this Agreement prior to such termination or Fraud, (ii) Sections 7 through
9 shall each survive the termination of this Agreement, and (iii) Sections 11 through 19 shall each survive the termination
of this Agreement solely to the extent related to any surviving sections. For purposes of this Section 7, (A) “Willful
Breach” means, with respect to any agreement, a Party’s knowing and intentional material breach of any of its representations
or warranties as set forth in such agreement, or such Party’s material breach of any of its covenants or other agreements set forth
in such agreement, which material breach constitutes, or is a consequence of, a purposeful act or failure to act by such Party with the
actual knowledge that the taking of such act or failure to take such act would cause a material breach of such agreement and (B) “Fraud”
means an actual and intentional fraud with respect to the making of the representations and warranties pursuant to Section 6; provided,
that such actual and intentional fraud of such Person shall only be deemed to exist if such Required Member had actual knowledge (as opposed
to imputed or constructive knowledge) that the representations and warranties made by it pursuant to Section 6 were actually breached
when made, with the express intention that the other Parties to this Agreement rely thereon to their detriment. For the avoidance of doubt,
“Fraud” does not include any claim for equitable fraud, promissory fraud, unfair dealings fraud or any torts (including
a claim for fraud or alleged fraud) based on negligence or recklessness.

 

8. No
Recourse. Each Party agrees that (a) this Agreement may only be enforced against, and any action for breach of this Agreement may
only be made against, the Parties, and no claims of any nature whatsoever (whether in tort, contract or otherwise) arising under or relating
to this Agreement, the negotiation hereof or its subject matter, or the transactions contemplated hereby shall be asserted against any
Company Non-Party Affiliate or any Acquiror Non-Party Affiliate, and (b) none of the Company Non-Party Affiliates or the Acquiror Non-Party
Affiliates shall have any liability arising out of or relating to this Agreement, the negotiation hereof or its subject matter, or the
transactions contemplated hereby, including with respect to any claim (whether in tort, contract or otherwise) for breach of this Agreement
or in respect of any written or oral representations made or alleged to be made in connection herewith, as expressly provided herein,
or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished
in connection with this Agreement, the negotiation hereof or the transactions contemplated hereby. For purposes of this Section 8,
(i) “Acquiror Non-Party Affiliate” means (A) any officer, director, employee, partner, member, manager, direct or
indirect equityholder or Affiliate of either Acquiror or Sponsor and (B) each of the former, current or future Affiliates, Representatives,
successors or permitted assigns of any of the Persons referred to in the immediately preceding clause (i)(A) (other than, for
the avoidance of doubt, Acquiror) and (ii) “Company Non-Party Affiliate” means (A) any officer, director, employee,
partner, member, manager, direct or indirect equityholder or Affiliate of the Company or any of its Subsidiaries (other than, for the
avoidance of doubt, the Company or any of its Subsidiaries) or any family member of the foregoing Persons and (B) each of the former,
current or future Affiliates, Representatives, successors or permitted assigns of any of the Persons in the immediately preceding clause
(ii)(A) (other than, for the avoidance of doubt, the Company or any of its Subsidiaries).

 

    6

    

    

 

9. Fiduciary
Duties. Notwithstanding anything in this Agreement to the contrary, (a) the Required Members make no agreement or understanding herein
in any capacity other than in the Required Members’ capacity as a record holder and beneficial owner of the Subject Company Equity
Securities and (b) nothing herein will be construed to limit or affect any action or inaction expressly permitted under the Merger Agreement
by any representative of the Required Members in such representative’s capacity as a member of the board of managers (or other
similar governing body) of the Company or as an officer, employee or fiduciary of the Company or an Affiliate of the Company, in each
case, acting in such person’s capacity as a director, officer, employee or fiduciary of the Company.

 

10. Further
Assurances. From time to time, at the Company’s or Acquiror’s reasonable request and without further consideration, each
Party shall execute and deliver such additional documents and take all such further action as may be reasonably necessary or reasonably
requested to effect the actions and consummate the transactions contemplated by this Agreement. The Required Members further agree not
to commence or participate in, and to take all actions necessary to opt out of any class in any class action with respect to, any action
or claim, derivative or otherwise, against Acquiror, Acquiror’s Affiliates, the Company or the Company’s Affiliates or any
of their respective successors and assigns challenging the transactions contemplated by this Agreement or the Merger Agreement.

 

11. Third-Party
Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and permitted assigns
and is not intended, nor shall be construed, to give any Person, other than the Parties and their respective successors and assigns,
any legal or equitable right, benefit or remedy of any nature whatsoever by reason of this Agreement. Nothing in this Agreement, expressed
or implied, is intended to or shall constitute a joint venture between the Parties.

 

12. Governing
Law; Jurisdiction; Venue; Service of Process; Waiver of Jury Trial. 

 

(a) This
Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation,
inducement to enter and/or performance of this Agreement (whether related to breach of contract, tortious conduct or otherwise and whether
now existing or hereafter arising) shall be governed by, the internal Laws of the State of Delaware, without giving effect to any Laws
(whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than
the State of Delaware.

 

(b) Subject
to Section 12(c), each Party, by its execution hereof, hereby (i) irrevocably submits to the exclusive jurisdiction Delaware Court
of Chancery or, if jurisdiction is unavailable in the Delaware Court of Chancery, the courts of the United States located in the State
of Delaware or, if jurisdiction is unavailable in the courts of the United States located in the State of Delaware, the Delaware Superior
Court, for the purpose of any lawsuit between or among the Parties arising in whole or in part under or in connection with this Agreement
or any other Transaction Agreement, (ii) waives and agrees not to assert, by way of motion, as a defense or otherwise, in any such lawsuit,
any claim that (A) it is not subject personally to the jurisdiction of the above-named courts, (B) its property is exempt or immune from
attachment or execution, (C) any such lawsuit brought in one of the above-named courts should be dismissed on grounds of forum non conveniens,
should be transferred or removed to any court other than one of the above-named courts, or should be stayed by reason of the pendency
of some other proceeding in any other court other than one of the above-named courts, or (D) this Agreement or any other Transaction
Agreement or the subject matter hereof or thereof may not be enforced in or by such court, and (iii) agrees not to commence any such
lawsuit other than before one of the above-named courts. Notwithstanding the preceding sentence, a Party may commence any lawsuit in
a court other than the above named courts solely for the purpose of enforcing an order issued by one of the above named courts.

 

    7

    

    

 

(c) If, and only if, the Delaware Court of Chancery, the courts of the United States located in the State of Delaware or the Delaware
Superior Court would not have jurisdiction over all or any portion of legal proceeding based upon, arising out of or related to this Agreement
or any of the Transactions (all or such portion of any such legal proceeding so declined by the Delaware Court of Chancery, the courts
of the United States located in the State of Delaware and the Delaware Superior Court, an “Arbitration Action”), the
Parties hereto agree that the Arbitration Action will be finally settled by binding arbitration in accordance with the then effective
Commercial Arbitration Rules of the American Arbitration Association by a panel of 3 arbitrators mutually agreeable to the Parties. If
the Parties in the Arbitration Action cannot mutually agree upon the selection, the arbitrators shall be selected in accordance with the
rules of the then effective Commercial Arbitration Rules of the American Arbitration Association. To the extent not governed by such rules,
such arbitrators shall be directed by the Parties in the Arbitration Action to set a schedule for determination of such dispute, claim
or controversy that is reasonable under the circumstances. Such arbitrators shall be directed by the Parties in the Arbitration Action
to determine the dispute in accordance with this Agreement and the substantive rules of law (but not the rules of procedure or evidence)
that would be applied by a federal court required to apply the internal law (and not the law of conflicts) of the State of Delaware. The
arbitration will be conducted in the English language in Palm Beach County, Florida. Judgment upon the award rendered by the arbitrators
may be entered by any court having jurisdiction. For the avoidance of doubt, nothing in this Section 12(c) shall prevent any Party
from seeking interim injunctive relief in the Delaware Court of Chancery, the courts of the United States located in the State of Delaware
or the Delaware Superior Court to prevent irreparable injury pending appointment of the arbitrators pursuant to this Section 12(c).

  

(d) Each
Party hereby (i) consents to service of process in any lawsuit between or among the Parties arising in whole or in part under or in connection
with this Agreement or any other Transaction Agreement in any manner permitted by the Laws of the State of Delaware, (ii) agrees
that service of process made in accordance with clause (i) above, or made by registered or certified mail, return receipt requested,
at its address specified in Section 17, will constitute good and valid service of process in any such lawsuit, and (iii) waives
and agrees not to assert (by way of motion, as a defense, or otherwise) in any such lawsuit any claim that service of process made in
accordance with clause (i) or clause (ii) above does not constitute good and valid service of process.

 

    8

    

    

 

(e) EACH
PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM
(WHETHER BASED UPON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE OTHER DOCUMENTS EXECUTED AND DELIVERED
IN CONNECTION HEREWITH, OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

 

13. Assignment.
No Party shall assign this Agreement or any part hereof without the prior written consent of the other Parties. Subject to the foregoing,
this Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors and assigns. Any
attempted assignment in violation of the terms of this Section 12 shall be null and void, ab initio.

 

14. Amendment.
This Agreement may be amended or modified in whole or in part, only by a duly authorized agreement in writing executed by each of the
Parties in the same manner as this Agreement and which makes reference to this Agreement.

 

15. Enforcement.
The Parties hereto agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would
occur in the event that the Parties do not perform their obligations under the provisions of this Agreement in accordance with its specified
terms or otherwise breach such provisions. The Parties hereto acknowledge and agree that (a) the Parties shall be entitled to an injunction,
specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions
hereof, including the Required Member’s obligations to vote its Required Company Equity Securities as provided in this Agreement,
without proof of damages, prior to the valid termination of this Agreement, this being in addition to any other remedy to which they
are entitled under this Agreement, and (b) the right of specific enforcement is an integral part of the transactions contemplated by
this Agreement and without that right, none of the Parties would have entered into this Agreement. Each Party agrees that it will not
oppose the granting of specific performance and other equitable relief on the basis that the other Parties have an adequate remedy at
applicable Law or that an award of specific performance is not an appropriate remedy for any reason at applicable Law or equity. The
Parties acknowledge and agree that any Party seeking an injunction to prevent breaches of this Agreement and to enforce specifically
the terms and provisions of this Agreement in accordance with this Section 15 shall not be required to provide any bond or other
security in connection with any such injunction.

 

16. Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this
Agreement shall remain in full force and effect. The Parties further agree that if any provision contained herein is, to any extent,
held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render
the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary,
shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a
valid and enforceable provision giving effect to the intent of the Parties.

 

    9

    

    

 

17. Notices.
All notices and other communications among the Parties shall be in writing and shall be deemed to have been duly given (a) when delivered
in person, (b) when delivered after posting in the United States mail having been sent registered or certified mail return receipt requested,
postage prepaid, (c) when delivered by FedEx or other nationally recognized overnight delivery service or (d) when e-mailed during normal
business hours (and otherwise as of the immediately following Business Day), addressed as follows:

 

If prior to the Closing, to the Company:

 

Benjamin & Brothers, LLC

390 N Orange Ave #1605

Orlando, FL 32801

Attn: Yatin Patel, Co-Founder

E-mail: yatin@reservations.com

 

with a copy (which shall not constitute notice) to:

 

Katz Teller

255 East Fifth Street, Suite 2400

Cincinnati, OH 45202

Attn: Gabriel J. Kurcab, Esq.

Email: gkurcab@katzteller.com

 

If prior to the Closing, to Acquiror:

 

Astrea Acquisition Corp.

55 Ocean Lane Drive, Apt. 3021

Key Biscayne, Florida 33149

Attention: Felipe Gonzalez

E-mail: fgonzalez@strongrockcap.com

 

with a copy (which shall not constitute
notice) to:

 

Graubard Miller

405 Lexington Avenue, 11th Floor

New York, New York 10174

Attention: Jeff Gallant, Esq.

Email: jgallant@graubard.com

 

If to the Company or Acquiror following the Closing:

 

Lexyl Travel Technologies, LLC

205 Datura St., 10th Floor

West Palm Beach, FL 33401

Attn: Tim Hentschel, Chief Executive
Officer

E-mail: tim.hentschel@HotelPlanner.com.com

 

    10

    

    

 

with copies (which shall not constitute
notice) to:

 

 Gunster

777 South Flagler Drive

Suite 500 East

West Palm Beach, FL 33401-6194

Attn: David G. Bates, Esq.

Milton Vescovacci, Esq.

Mahesh Nanwani, Esq.

Robert Lamm, Esq.

Email: dbates@gunster.com

mvescovacci@gunster.com

mnanwani@gunster.com

rlamm@gunster.com

 

Latham & Watkins LLP

811 Main Street, Suite 3700

Houston, TX 77002

Attention: Ryan Maierson

Tana Ryan

Navneeta Rekhi

Email: ryan.maierson@lw.com

tana.ryan@lw.com

navneeta.rekhi@lw.com

 

If
to the Required Members, at the address for such Required Member listed on the signature pages hereto, or to such other address or addresses
as the Parties may from time to time designate in writing. Without limiting the foregoing, any Party may give any notice, request, instruction,
demand, document or other communication hereunder using any other means (including personal delivery, expedited courier, messenger service,
ordinary mail or electronic mail), but no such notice, request, instruction, demand, document or other communication shall be deemed
to have been duly given unless and until it actually is received by the Party for whom it is intended.

 

18. Captions;
Counterparts. The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction
or interpretation of any provision of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument.

 

19. Entire
Agreement. This Agreement constitutes the entire agreement among the Parties relating to the subject matter hereof and supersedes
any other agreements, whether written or oral, that may have been made or entered into by or among any of the Parties or any of their
respective Subsidiaries relating to the subject matter hereof. No representations, warranties, covenants, understandings, agreements,
oral or otherwise, relating to the subject matter hereof exist between the Parties except as expressly set forth or referenced herein.

 

[Signature
Pages Follow]

 

    11

    

    

 

IN
WITNESS WHEREOF, each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above
written.

 

	 	ASTREA
Acquisition Corp.

	 	 
	 	By:	     
	 	 	Name:	                       
	 	 	Title:	 

 

	 	BENJAMIN & BROTHERS, LLC
	 	 
	 	By:	 
	 	 	Name:	                        
	 	 	Title:	 

 

Signature Page to Member Support Agreement

 

    

    

    

 

	 
	REQUIRED
                                            mEMBERS:

	 	 
	 	[●]

 

	 	By:	        
	 	Name:	 
	 	Title:	 

 

 

Signature Page to Member Support Agreement

 

    

    

    

 

SCHEDULE
I

 

Required
Members

 

	Required Member	 	Class of Units	 	Number of UnitsExhibit 4.1
​
​
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
​
UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE SEPTEMBER [●], 2021.
​
MILESTONE PHARMACEUTICALS INC.
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON SHARES
​
Number of Shares: [●] (subject to adjustment)
​
	Warrant No. PFW2021 - [ ]
	Original Issue Date: May [●], 2021

​
Milestone Pharmaceuticals Inc., an exempted company incorporated and existing under the laws of the Province of Québec, Canada (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [] or its registered assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company up to a total of [●] common shares, no par value per share (the “Common Shares”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price per share equal to $0.01 per share (as adjusted from time to time as provided in Section 9 herein, the “Exercise Price”) upon surrender of this Warrant to Purchase Common Shares (including any Warrants to Purchase Common Shares issued in exchange, transfer or replacement hereof, the “Warrant”) at any time and from time to time on or after the date hereof (the “Original Issue Date”) until the Warrant has been exercised in full, subject to the following terms and conditions:

		1.	Definitions. For purposes of this Warrant, the following terms shall have the following meanings:

(a)“Affiliate” means any Person directly or indirectly controlled by, controlling or under common control with, a Holder, as such terms are used in and construed under Rule 405 under the Securities Act, but only for so long as such control shall continue.
​
		(b)	“Commission” means the United States Securities and Exchange Commission.

​
(c)“Closing Sale Price” means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as reported by Bloomberg L.P., or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg L.P., or if the security is not listed for trading on a national securities exchange or other trading market on the relevant date, the last quoted bid price for the security in the over-the-counter market on the relevant date as reported by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined in good faith by the Company and the Holder. All such determinations shall be appropriately adjusted for any share dividend, share split, share combination or other similar transaction during the applicable calculation period.
​
(d)“Principal Trading Market” means the national securities exchange or other trading market on which the Common Shares are primarily listed on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Select Market.
​

		(e)	“Securities Act” means the Securities Act of 1933, as amended.

​

(f)“Trading Day” means any weekday on which the Principal Trading Market is open for trading. If the Common Shares are not listed or admitted for trading, “Trading Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in New York City are authorized or required by law or other governmental action to close.
​
(g)“Transfer Agent” means Computershare Investor Services Inc. and Computershare Trust Company, N.A., collectively, the Company’s transfer agent and registrar for the Common Share, and any successor appointed in such capacity.
​
2.Warrant Register. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned hereunder) from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
​
3.Registration of Transfers. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a new warrant to purchase Common Shares in substantially the form of this Warrant (any such new warrant, a “New Warrant”) evidencing the portion of this Warrant so transferred shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company’s own expense any New Warrant under this Section 3. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.
​
		4.	Exercise and Duration of Warrants.

​
(a)All or any part of this Warrant shall be exercisable by the registered Holder in the manner set forth in Section 4(b) at any time and from time to time on or after the Original Issue Date subject to the limitations set forth in Section 11.
​
(b)The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto (the “Exercise Notice”), completed and duly signed, and (ii) payment of the Exercise Price (if applicable) in cash or immediately available funds (or pursuant to cashless exercise provisions in accordance herewith and with Section 10) for the number of Warrant Shares as to which this Warrant is being exercised. The date on which such Exercise Notice is delivered to the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.” The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares, if any. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
​
		5.	Delivery of Warrant Shares.

​
(a)The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company (“DTC”) through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by issuing such Warrant Shares in the name of the Holder or its designee in restricted book-entry form in
​

the Company’s share register, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice of Exercise and delivery of the aggregate Exercise Price (if applicable) to the Company. The Holder, or any natural person or legal entity (each, a “Person”) so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of restricted book-entry evidencing such Warrant Shares, as the case may be.
​
(b)If by the close of the second (2nd) Trading Day after the Exercise Date, the Company fails to deliver to the Holder the required number of Warrant Shares in the manner required pursuant to Section 5(a) or fails to credit the Holder’s DTC account for such number of Warrant Shares to which the Holder is entitled, and if after such third (3rd) Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall, within two (2) Trading Days after the Holder’s request promptly honor its obligation to deliver to the Holder such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if any) of Holder’s total purchase price (including brokerage commissions, if any) for the Common Shares so purchased in the Buy-In less the product of (A) the number of Common Shares purchased in the Buy-In, times (B) the Closing Sale Price of a Common Share on the Exercise Date.
​
(c)To the extent permitted by law and subject to Section 5(b), the Company’s obligations to issue and deliver Warrant Shares in accordance with and subject to the terms hereof (including the limitations set forth in Section 11 below) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Subject to Section 5(b), nothing herein shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.
​

6.Charges, Taxes and Expenses. Issuance and delivery of Common Shares upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.
​

7.Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable indemnity and surety bond, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s obligation to issue the New Warrant.
​

8.No Pre-Emptive Rights; Duly Issued Warrant Shares. The Company covenants that all Warrant Shares issuable and deliverable upon exercise in full of this Warrant shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable. The Company will take all such action as may be reasonably necessary to assure that such Common Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which the Common Shares may be listed.
​
		9.	Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are

​

subject to adjustment from time to time as set forth in this Section 9.
​

(a)Share Dividends and Splits. If the Company, at any time while this Warrant is issued and outstanding, (i) pays a share dividend on its Common Shares or otherwise makes a distribution on any class of capital shares issued and outstanding on the Original Issue Date and in accordance with the terms of such shares on the Original Issue Date or as amended, that is payable in Common Shares, (ii) subdivides its issued and outstanding Common Shares into a larger number of Common Shares, (iii) combines its issued and outstanding Common Shares into a smaller number of Common Shares or (iv) issues by reclassification of capital shares any additional Common Shares of the Company, then in each such case the Exercise Price shall be multiplied by a fraction, the numerator of which shall be the number of Common Shares issued and outstanding immediately before such event and the denominator of which shall be the number of Common Shares issued and outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the Exercise Price shall be recomputed accordingly as of the close of business on such record date and thereafter the Exercise Price shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.
​
(b)Pro Rata Distributions. If the Company, at any time while this Warrant is issued and outstanding, distributes to all holders of Common Shares for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Shares covered by the preceding paragraph), (iii) rights or warrants to subscribe for or purchase any security, or (iv) cash or any other asset (in each case, a “Distribution”), other than a reclassification as to which Section 9(c) applies, then in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the ownership limitation set forth in Section 11(a) hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the ownership limitation set forth in Section 11(a) hereof, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent)) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until the earlier of (i) such time, if ever, as the delivery to such Holder of such portion would not result in the Holder exceeding the ownership limitation set forth in Section 11(a) hereof and (ii) such time as the Holder has exercised this Warrant.
​
(c)Fundamental Transactions. If, at any time while this Warrant is issued and outstanding (i) the Company effects any amalgamation, merger or consolidation of the Company with or into another Person, in which the Company is not the surviving entity and in which the shareholders of the Company immediately prior to such amalgamation, merger or consolidation do not own, directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such amalgamation, merger or consolidation, (ii) the Company effects any sale to another Person of all or substantially all of its assets in one transaction or a series of related transactions, (iii) pursuant to any tender offer or exchange offer (whether by the Company or another Person), holders of share capital tender shares representing more than 50% of the voting power of the capital shares of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than the 50% of the voting power of the capital shares of the Company (except for any such transaction in which the shareholders of the Company immediately prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction) or (v) the Company effects any reclassification of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of Common Shares covered by Section 9(a) above) (in any such case, a “Fundamental Transaction”), then following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard to any limitations on exercise contained herein (the “Alternate Consideration”). The
​

Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous “cashless exercise” of this Warrant pursuant to Section 10 below or (ii) prior to or simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The provisions of this paragraph (c) shall similarly apply to subsequent transactions analogous of a Fundamental Transaction type.
​
(d)Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to Section 9 (including any adjustment to the Exercise Price that would have been effected but for the final sentence in this paragraph (d)), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price (if applicable) payable hereunder for the increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.
​
(e)Calculations. All calculations under this Section 9 shall be made to the nearest one-millionth of one cent or the nearest share, as applicable.
​
(f)Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will, at the written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s transfer agent.
​
(g)Notice of Corporate Events. If, while this Warrant is issued and outstanding, the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Shares, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital shares of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits shareholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such transaction at least ten (10) days prior to the applicable record or effective date on which a Person would need to hold Common Shares in order to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice. In addition, if while this Warrant is issued and outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits shareholder approval for any Fundamental Transaction contemplated by Section 9(c), other than a Fundamental Transaction under clause (iii) of Section 9(c), then, except if such notice and the contents thereof shall be deemed to constitute material non-public information, the Company shall deliver to the Holder a notice of such Fundamental Transaction at least ten (10) days prior to the date such Fundamental Transaction is consummated.
​
10.Payment of Cashless Exercise Price. Upon the cashless exercise of this Warrant pursuant to Section 4(b) or Section 9(c) hereof, the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act as determined as follows:
X = Y [(A-B)/A]
​
where:
“X” equals the number of Warrant Shares to be issued to the Holder;
​
“Y” equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;
​
“A” equals the Closing Sale Price per Common Share as of the Trading Day on the date immediately preceding the Exercise Date; and
​

“B” equals the Exercise Price per Warrant Share then in effect on the Exercise Date.
​
For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in such a “cashless exercise” transaction pursuant to Section 9(c) hereof shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise).
​
For the avoidance of doubt, any exercise of this Warrant pursuant to Section 4 hereof shall only be settled in cash.
​
		11.	Limitations on Exercise.

​
(a)Notwithstanding anything to the contrary contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect or immediately prior to such exercise, would cause (i) the aggregate number of Common Shares beneficially owned by the Holder, its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) to exceed 9.99% (the “Maximum Percentage”) of the total number of issued and outstanding Common Shares of the Company following such exercise, or (ii) the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) to exceed 9.99% of the combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding Common Shares, the Holder may rely on the number of outstanding Common Shares as reflected in (x) the Company’s most recent Form 10-Q or Form 10-K, as the case may be, filed with the Commission prior to the date hereof, (y) a more recent public announcement by the Company or (z) any other notice by the Company or its transfer agent setting forth the number of Common Shares outstanding. Upon the written request of the Holder, the Company shall within two (2) Trading Days confirm in writing or by electronic mail to the Holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding Common Shares was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage specified not in excess of 9.99% as specified in such notice; provided that any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For purposes of this Section 11(a), the aggregate number of Common Shares or voting securities beneficially owned by the Holder and its Affiliates and any other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”) shall include the Common Shares issuable upon the exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (x) exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power (including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Shares, including without limitation any debt, preferred share, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Shares), is subject to a limitation on conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and other Persons whose beneficial ownership of Common Shares would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act (such as any other members of a Section 13(d) “group”).
​

(b)This Section 11 shall not restrict the number of Common Shares that a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant.
​
12.No Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company shall pay the Holder in cash the fair market value (based
​

on the Closing Sale Price) for any such fractional shares.
​

13.Notices. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via confirmed e-mail prior to 5:30 P.M., New York City time, on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery. The addresses and e-mail addresses for such communications shall be:
If to the Company:
​
Attention: Amit Hasija, Chief Financial Officer Milestone Pharmaceuticals Inc.
1111 Dr. Frederik-Philips Blvd., Suite 420 Montréal, Québec H4M 2X6
Email: ahasija@milestonepharma.com
​
with copies (which shall not constitute notice) to:
​
Attention: Ryan Sansom Cooley LLP
500 Boylston Street, 14th Floor Boston, Massachusetts 02116
Facsimile: (617) 937-2400 Email: rsansom@cooley.com
​
​
If to the Holder, to its address or e-mail address set forth herein or on the books and records of the Company.
​
Or, in each of the above instances, to such other address or e-mail address as the recipient party has specified by written notice given to each other party at least five (5) days prior to the effectiveness of such change.
​
14.Warrant Agent. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10) days’ notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation or amalgamation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.
​
		15.	Miscellaneous.

​
(a)No Rights as a Shareholder. The Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of shares, reclassification of shares, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.
​

(b)Successors and Assigns. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns.
​
(c)Amendment and Waiver. Except as otherwise provided herein, this Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.
​
(d)Acceptance. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.
​
(e)Governing Law; Jurisdiction. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.
​
(f)Headings. The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.
​
(g)Severability. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
​
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
​

IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.
​
	MILESTONE PHARMACEUTICALS INC.

	By:  ​ ​
	​

	Name:
	Joseph G. Oliveto

	Title:
	President and CEO

​

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]